Schizophrenia and amphetamine dependence. A case report;Schizophrénie et dépendance aux amphétamines

Encephale

Volumn 31, Issue 2, 2005, Pages 247-250

  Dervaux, A ^a,b,c   Krebs, M O ^b,c   Laqueille, X ^b  

^a Centre Hospitalier General   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

^c INSERM   (France)

Author keywords

Amphetamine abuse; Amphetamine dependence; Schizophrenia

Indexed keywords

AMPHETAMINE; OLANZAPINE;

ADULT; AMYGDALOID NUCLEUS; ANAMNESIS; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; CAUDATE NUCLEUS; CHRONIC DRUG ADMINISTRATION; CORPUS STRIATUM; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; EXPERIMENTAL ANIMAL; FRONTAL CORTEX; GRANDIOSE DELUSION; HEBEPHRENIA; HOMICIDE; HUMAN; MALE; NEGATIVE SYNDROME; NERVE DEGENERATION; NUCLEUS ACCUMBENS; PARAPSYCHOLOGY; PERSECUTORY DELUSION; PUTAMEN; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; THOUGHT DISORDER; VISUAL HALLUCINATION; WITHDRAWAL SYNDROME;

EID: 18744369050     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0013-7006(05)82391-7     Document Type: Article

References (28)

1. CHAMBERS RA, KRYSTAL JH, SELF DW. A neurological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 2001; 50: 71-83.
2. CHARLES-NICOLAS AJ. La psychose chronique due à l'abus des amphétamines existe-t-elle? Étude de 25 toxicomanes. Nouv Presse Med 1976; 5: 2447-50.
3. COTTEREAU MJ, LOO H, POIRIER MF et al. Les pharmacopsychoses au cours des toxicomanies. Encephale 1975; 1: 43-8.
4. DELAY J, PICHOT P, LEMPERIERE T et al. Psychoses amphétaminiques et pseudopsychoses amphétaminiques. Ann Med Psychol 1954; 2: 51-7.
5. DENG X, CAI NS, MCCOY MT et al. Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway. Neuropharmacology 2002; 42: 837-45.
6. DENIKER P, COTTEREAU MJ, LOO H. Toxicomanies aux amphétamines. Rev Med 1972; 31: 2061-3.
7. DERVAUX A, BAYLE FJ, LAQUEILLE X et al. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? Am J Psychiatry 2001; 158: 492-4.
8. DERVAUX A, BAYLE FJ, KREBS MO. Substance misuse among people with schizophrenia: similarities and differences between the UK and France. Br J Psychiatry 2002; 180: 381.
9. DUAUX E, DERVAUX A. Toxicomanie et schizophrénie. In: Gérard A, Lôo H, Olié JP, eds. Séminaire de Psychiatrie Biologique de l'hôpital Sainte-Anne. Paris: Aventis 2000; 30: 93-112.
10. FLAUM M, SCHULTZ SK. When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry 1996; 153: 812-5.
11. GOLDBERG TE, BIGELOW LB, WEINBERGER DR et al. Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia. Am J Psychiatry 1991; 148: 78-84.
12. GUT-FAYAND A, DERVAUX A, OLIÉ JP et al. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res 2001; 102: 65-72.
13. IWANAMI A, SUGIYAMA A, KUROKI N et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatr Scand 1994; 89: 428-32.
14. JANOWSKY DS, DAVIS JM. Methylphenidate, dextroamphetamine and levamfetamine. Effects on schizophrenic symptoms. Arch Gen Psychiatry 1976; 33: 304-8.
15. JANOWSKY DS, RISCH C. Amphetamine psychosis and psychotic symptoms. Psychopharmacology 1979; 65: 73-7.
16. KREBS M-O, GOLDBERGER C, DERVAUX A. Est-il possible d'établir un lien de causalité entre abus de substances et schizophrénie débutante? Conférence de consensus «Schizophrénies débutantes: diagnostic et modalités thérapeutiques »organisée par la Fédération Française de Psychiatrie. Hôpital Sainte-Anne, Paris, 23-24 janvier 2003. John Libbey Eurotext 2003: 159-74.
17. LEDUC PA, MITTLEMAN G. Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence. Psychopharmacology 1995; 121: 407-27.
18. LIEBERMAN JA, KANE JM, ALVIR J. Provocative tests with psychostimulant drug in schizophrenia. Psychopharmacology 1987; 91: 415-33.
19. LIEBERMAN JA, KINON BJ, LOEBEL AD. Dopaminergic mechanism in idiopathic and drug-induced psychoses. Schizophr Bull 1990; 16: 97-110.
20. LINNOILA M. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differenciates impulsive from non impulsive violent behavior. Life Sci 1983; 33: 2609-14.
21. MCLELLAN AT, WOODY GE, O'BRIEN CP. Development of psychiatric disorders in drug abusers. NEJM 1979; 301: 1310-3.
22. MICZEK KA, TIDEY JW. Amphetamines: aggressive and social behavior. NIDA Res Monogr 1989; 94: 68-100.
23. REGIER DA, FARMER ME, RAE DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990; 264: 2511-8.
24. SATO M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci 1992; 654: 160-70.
25. SEKINE Y, IYO M, OUCHI Y et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 2001; 158: 1206-14.
26. SOYKA M. Substance misuse, psychiatric disorder and violent and disturbed behaviour. Br J Psychiatry. 2000; 176: 345-50.
27. VAN KAMMEN DP, BORONOW JJ. Dextro-amphetamine diminishes negative symptoms in schizophrenia. Int Clin Psychopharmacol 1988; 3: 111-21.
28. 11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 1998; 18: 419-27.